학술논문

A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patients
Document Type
Article
Source
In: Biomedicine and Pharmacotherapy. (Biomedicine and Pharmacotherapy, May 2024, 174)
Subject
Language
English
ISSN
19506007
07533322